Parallel by design
Imaging, genomics, pharmacology, prediction and management run simultaneously, each with its own models resident in memory — no contention, no missed clinical deadlines.
Technical partner · National Healthcare Digitalization Program 2025–2030
IMPORT MEDICAL delivers AI‑powered diagnostics, genomics, treatment planning and healthcare management — running on sovereign, high‑performance computing capacity hosted entirely within the Republic of Moldova.
IMPORT MEDICAL is a Moldovan company specialising in the import, deployment and integration of medical technology and clinical artificial intelligence. As a technical partner of the National Healthcare Digitalization Program of the Republic of Moldova (2025–2030), we bring together three things that rarely sit under one roof: access to leading global medical and computing technology, the AI expertise to make it clinically useful, and sovereign computing capacity that keeps patient data inside the country.
What we do
One accountable partner from procurement to production.
Sourcing, certification, customs and delivery of medical equipment and high‑performance computing hardware.
Learn moreDedicated, on‑premise accelerated computing in Moldova, engineered for clinical AI workloads and redundancy.
Learn moreDeployment, integration and validation of AI for imaging, genomics, pharmacology and disease prediction.
Learn moreMonitoring, model retraining on local data, testing environments and capacity planning as the system grows.
Learn moreSolutions
Each domain runs its own models on dedicated computing capacity, so time‑critical clinical services never compete for resources.
AI‑assisted reading for a national volume of roughly 350,000–400,000 studies per year, with critical findings such as stroke flagged to clinicians within minutes.
GPU‑accelerated genome analysis supporting population screening of about 1% of the population (~24,000 genomes), designed to scale as the programme expands.
A multimodal clinical model combining genetics, patient history, laboratory results, imaging and drug databases to support prescribing decisions.
Early risk prediction from cumulative patient records and real‑time epidemiological monitoring across the country.
Operational intelligence that helps institutions plan medicines, stock, staff and budgets with data.
Sovereign AI computing
Clinical AI is only as reliable as the infrastructure beneath it. We provide dedicated, on‑premise accelerated computing engineered specifically for healthcare workloads.
Imaging, genomics, pharmacology, prediction and management run simultaneously, each with its own models resident in memory — no contention, no missed clinical deadlines.
Medical data of Moldovan citizens is processed exclusively within the country. No foreign public cloud — the entire platform runs on‑premise.
EHR coverage is set to rise from under 10% to 80% by 2030. Capacity, redundancy and development environments are planned for that growth from day one.
How we deliver
Workload analysis — study volumes, model needs, service levels and growth.
Manufacturer negotiation, logistics, customs and certification.
On‑premise installation, model deployment and integration with hospital systems.
Clinical validation in a dedicated test environment before go‑live.
Monitoring, retraining on local data and capacity expansion.
Insights
Capacity for national healthcare AI is not one number. It is the sum of several workloads with different shapes, plus redundancy and room to grow. Here is a step-by-step way to plan it.
A 2023 Lancet trial showed that a 12-gene pharmacogenomic panel cut clinically relevant adverse drug reactions by about 30%. Here is what the evidence shows, how Estonia returns PGx results to its population, and what implementation takes.
Clinical AI gets the headlines, but much of the money and many avoidable harms sit in operations: empty shelves, overstocked warehouses, understaffed shifts and improper payments. Here is what has worked.
FAQ
We import medical technology and high‑performance computing equipment into the Republic of Moldova and implement AI solutions on top of it — for medical imaging, genomics, pharmacology and treatment planning, disease prediction and healthcare management — including deployment, validation and ongoing operation.
Exclusively within the Republic of Moldova, on dedicated on‑premise infrastructure. Our architecture does not send patient data to foreign public clouds.
No. Our solutions are decision‑support tools: they prioritise urgent cases, highlight findings and suggest options, while diagnosis and treatment decisions remain with qualified clinicians.
Both. The same solutions that serve the national programme can be deployed for an individual hospital, laboratory or diagnostic centre.
Talk to our team about specification, supply, deployment and support — from a single hospital department to a national programme.